CYP4F10P

Across TCGA pan-cancer cohorts, CYP4F10P RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of CYP4F10P’s most consistent transcriptional readouts.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where CYP4F10P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types CYP4F10P is over-expressed in tumor, although a few such as BRCA show the opposite, repressed pattern.

LIHC, BRCA, and LUSC are the cancer types where CYP4F10P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in CYP4F10P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LIHC	Male	All	+0.038	.014	2	view →
BRCA	All	All	−0.007	.033	2	view →
LUSC	Male	All	+0.044	.048	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

CYP4F10P–LIHC

Open the LIHC breakdown →